MS-553 in Diabetic Retinopathy Patients With Central Involved Macular Edema

Conditions:   Diabetic Macular Edema;   Macular Edema;   Type 2 Diabetes With Diabetic Macular Edema;   Type 1 Diabetes With Diabetic Macular Edema;   Diabetic Retinopathy Intervention:   Drug: MS-553 Sponsors:   Shenzhen MingSight Relin Pharmaceuticals Co., Ltd.;   Fountain Medical Development Co., Ltd. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials